KNTE
Fidelity Investments’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-674,047
| Closed | -$2.04M | – | 5590 |
|
|
2023
Q2 | $2.04M | Sell |
674,047
-972,342
| -59% | -$2.95M | ﹤0.01% | 2306 |
|
|
2023
Q1 | $10.3M | Sell |
1,646,389
-441,888
| -21% | -$2.76M | ﹤0.01% | 1864 |
|
|
2022
Q4 | $12.7M | Sell |
2,088,277
-341,825
| -14% | -$2.09M | ﹤0.01% | 1804 |
|
|
2022
Q3 | $29M | Buy |
2,430,102
+236,786
| +11% | +$2.83M | ﹤0.01% | 1475 |
|
|
2022
Q2 | $27.7M | Buy |
2,193,316
+749,012
| +52% | +$9.45M | ﹤0.01% | 1523 |
|
|
2022
Q1 | $16.3M | Sell |
1,444,304
-648,219
| -31% | -$7.3M | ﹤0.01% | 1884 |
|
|
2021
Q4 | $37.1M | Sell |
2,092,523
-4,823
| -0.2% | -$85.5K | ﹤0.01% | 1547 |
|
|
2021
Q3 | $48.3M | Sell |
2,097,346
-7,675
| -0.4% | -$177K | ﹤0.01% | 1425 |
|
|
2021
Q2 | $49M | Sell |
2,105,021
-26,627
| -1% | -$620K | ﹤0.01% | 1440 |
|
|
2021
Q1 | $65.1M | Sell |
2,131,648
-318,487
| -13% | -$9.73M | 0.01% | 1268 |
|
|
2020
Q4 | $94.1M | Buy |
+2,450,135
| New | +$94.1M | 0.01% | 1058 |
|